WCLC 2025 - Posters & ePosters-P1.07.47 Early Treatment Discontinuation of Osimertinib in the Adjuvant Setting: Insights From the ADAURA Study

P1.07.47 Early Treatment Discontinuation of Osimertinib in the Adjuvant Setting: Insights From the ADAURA Study

Asset Subtitle

Christian Grohé

Meta Tag

Speaker Christian Grohé

Topic Early-Stage Non-small Cell Lung Cancer